Display options
Cite
Ertuğrul S, Darakci SM, Kaplan İ, et al. The contribution of postnatal steroid administration to early brain damage in preterm babies with bronchopulmonary dysplasia. Turk J Med Sci. 2021;51(4):1917-1923doi: 10.3906/sag-2101-295.
Ertuğrul, S., Darakci, S. M., Kaplan, �. �., Yolbaş, �. �., Deger, �. �., Tanrıverdi Yilmaz, S., & Aktaş, �. �. (2021). The contribution of postnatal steroid administration to early brain damage in preterm babies with bronchopulmonary dysplasia. Turkish journal of medical sciences, 51(4), 1917-1923. https://doi.org/10.3906/sag-2101-295
Ertuğrul, Sabahattin, et al. "The contribution of postnatal steroid administration to early brain damage in preterm babies with bronchopulmonary dysplasia." Turkish journal of medical sciences vol. 51,4 (2021): 1917-1923. doi: https://doi.org/10.3906/sag-2101-295
Ertuğrul S, Darakci SM, Kaplan İ, Yolbaş İ, Deger İ, Tanrıverdi Yilmaz S, Aktaş Ş. The contribution of postnatal steroid administration to early brain damage in preterm babies with bronchopulmonary dysplasia. Turk J Med Sci. 2021 Aug 30;51(4):1917-1923. doi: 10.3906/sag-2101-295. PMID: 33819976; PMCID: PMC8569755.
Copy Download .nbib Format: NLM
Share it on

Turk J Med Sci. 2021 Aug 30;51(4):1917-1923. doi: 10.3906/sag-2101-295.

The contribution of postnatal steroid administration to early brain damage in preterm babies with bronchopulmonary dysplasia.

Turkish journal of medical sciences

Sabahattin Ertuğrul, Savaş Mert Darakci, İbrahim Kaplan, İlyas Yolbaş, İbrahim Deger, Sibel Tanrıverdi Yilmaz, Şerafettin Aktaş

Affiliations

  1. Department of Pediatrics, Division of Neonatology, Faculty of Medicine, Dicle University, Diyarbak?r, Turkey
  2. Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbak?r, Turkey
  3. Department of Biochemistry, Faculty of Medicine, Dicle University, Diyarbak?r, Turkey

PMID: 33819976 PMCID: PMC8569755 DOI: 10.3906/sag-2101-295

Abstract

BACKGROUND/AIM: Postnatal corticosteroids are commonly used to treat bronchopulmonary dysplasia (BPD). We aimed to show whether S100 calcium-binding B (S100B), neuron-specific enolase (NSE), Tau protein or microtubule-associated protein tau (MAPT), and glial fibrillary acid protein (GFAP) levels would provide any evidence of early neurological damage in premature infants receiving postnatal low dose dexamethasone therapy for BPD treatment.

MATERIALS AND METHODS: In this cohort study, 136 preterm infants diagnosed with BPD at ≤32 weeks of gestation formed the study group, and 64 preterm infants formed the control group. NSE, S100B, GFAP, and MAPT levels were first measured before the postnatal corticosteroid treatment in both the patient and the control group on the 28th day and, for a second time, after treatment termination in the patient group.

RESULTS: There were significant differences between the measured GFAP, MAPT, and NSE values of the BPD and control groups on the 28th day, whereas there was no significant difference between the measured S100B values of the two groups. There were a statistically significant difference between the NSE values measured on the 28th day and after the treatment within the BPD group, whereas no significant difference existed between the GFAP, MAPT, and S100B values.

CONCLUSION: NSE levels, which indicate brain damage in the early period, increased in preterm babies with BPD who had been administered postnatal dexamethasone.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Keywords: S100 proteins; glial fibrillary acidic protein; microtubule-associated proteins; neuron-specific enolase; Bronchopulmonary dysplasia

References

  1. Indian J Pediatr. 2020 Oct;87(10):787-792 - PubMed
  2. Brain Dev. 2004 Sep;26(6):398-402 - PubMed
  3. Cochrane Database Syst Rev. 2017 Jan 31;1:CD010941 - PubMed
  4. Neonatology. 2010;98(3):217-24 - PubMed
  5. J Pediatr. 2014 Dec;165(6):1258-60 - PubMed
  6. Pediatr Neonatol. 2015 Aug;56(4):261-7 - PubMed
  7. Steroids. 2016 Oct;114:25-32 - PubMed
  8. Am J Obstet Gynecol. 2011 Sep;205(3):251.e1-7 - PubMed
  9. J Paediatr Child Health. 2004 Mar;40(3):114-20 - PubMed
  10. Pediatrics. 2010 Sep;126(3):443-56 - PubMed
  11. J Matern Fetal Neonatal Med. 2019 Mar 28;:1-7 - PubMed
  12. Pediatrics. 2007 Apr;119(4):716-21 - PubMed
  13. PLoS One. 2020 Jun 1;15(6):e0234082 - PubMed
  14. Acta Paediatr. 2012 Aug;101(8):e316-20 - PubMed
  15. Pediatr Neurol. 2015 Feb;52(2):143-52 - PubMed
  16. Am J Perinatol. 2019 Jul;36(S 02):S58-S62 - PubMed
  17. Neonatology. 2017;112(1):60-66 - PubMed
  18. Front Biosci (Schol Ed). 2010 Jan 01;2:47-72 - PubMed
  19. Pediatrics. 1994 Feb;93(2):234-40 - PubMed
  20. PLoS One. 2017 Jul 19;12(7):e0181176 - PubMed
  21. Acta Paediatr. 2001 Oct;90(10):1171-5 - PubMed
  22. Clin Chem Lab Med. 2020 Mar 26;58(4):471-486 - PubMed
  23. BMC Pediatr. 2018 Feb 12;18(1):50 - PubMed
  24. J Matern Fetal Neonatal Med. 2018 Nov;31(21):2898-2904 - PubMed
  25. Pediatr Neonatol. 2017 Feb;58(1):70-76 - PubMed

Publication Types